Insights

A Dutch transaction timetable helps buyers, investors, founders and international counsel plan the legal and practical steps between signing and closing, including approvals, KYC, powers of attorney, notarial deeds, funds flow and closing deliverables.

The Dutch Vifo Act will be expanded as of 1 January 2027 with six technologies, including AI, biotechnology, advanced materials, nanotechnology, sensor and navigation technology and medical nuclear technology. For Dutch technology M&A, investment screening should be considered earlier in the deal process.

The European Commission wants to make Europe more attractive for startups and scale-ups. Its plans focus on less fragmentation, better access to finance, the Scaleup Europe Fund, deeptech, R&D, talent and more private investment. What does this mean for Dutch companies and investors?

A buyer that failed to dispute an earn-out in time under the SPA was held to the sellers’ calculation. This article explains the Amsterdam District Court judgment and the practical lessons for Dutch M&A, earn-outs, rollover arrangements and SPA drafting.

Nuclear technology investments in the Netherlands require careful legal review of IP, grants, strategic investors, governance, sensitive technology and supply-chain dependencies.

Dutch quantum and deeptech scale-ups should address IP ownership, grants, research arrangements, strategic investors, governance and future financing mechanics before raising capital.

Dutch and EU fintech scale-ups using AI agents should document controls around data access, customer impact, audit trails, vendor terms, human review and board oversight.

Founder and management reinvestment in Dutch PE platform combinations requires careful alignment of rollover equity, governance, leaver provisions and future add-on mechanics.

AI infrastructure investments in Dutch scale-ups require review of compute, vendor contracts, IP, data rights, customer commitments, governance and investor protections.